These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35337006)

  • 1. A Novel H-2
    Uddbäck I; Kohlmeier JE; Thomsen AR; Christensen JP
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broadly Protective CD8
    Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
    J Virol; 2021 May; 95(12):. PubMed ID: 33827939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses.
    Matyushenko V; Kotomina T; Kudryavtsev I; Mezhenskaya D; Prokopenko P; Matushkina A; Sivak K; Muzhikyan A; Rudenko L; Isakova-Sivak I
    Antiviral Res; 2020 Oct; 182():104864. PubMed ID: 32585323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal CD8+ T cell responses induced by an MCMV based vaccine vector confer protection against influenza challenge.
    Zheng X; Oduro JD; Boehme JD; Borkner L; Ebensen T; Heise U; Gereke M; Pils MC; Krmpotic A; Guzmán CA; Bruder D; Čičin-Šain L
    PLoS Pathog; 2019 Sep; 15(9):e1008036. PubMed ID: 31525249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice.
    Soboleski MR; Gabbard JD; Price GE; Misplon JA; Lo CY; Perez DR; Ye J; Tompkins SM; Epstein SL
    PLoS One; 2011; 6(7):e21937. PubMed ID: 21789196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single mucosal vaccination targeting nucleoprotein provides broad protection against two lineages of influenza B virus.
    Kim MH; Kang JO; Kim JY; Jung HE; Lee HK; Chang J
    Antiviral Res; 2019 Mar; 163():19-28. PubMed ID: 30639307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with an acidic polymerase epitope of influenza virus elicits a potent antiviral T cell response but delayed clearance of an influenza virus challenge.
    Crowe SR; Miller SC; Shenyo RM; Woodland DL
    J Immunol; 2005 Jan; 174(2):696-701. PubMed ID: 15634888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses.
    Quiñones-Parra SM; Clemens EB; Wang Z; Croom HA; Kedzierski L; McVernon J; Vijaykrishna D; Kedzierska K
    J Virol; 2016 Aug; 90(15):6936-6947. PubMed ID: 27226365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein.
    Mbawuike IN; Dillion SB; Demuth SG; Jones CS; Cate TR; Couch RB
    Vaccine; 1994 Nov; 12(14):1340-8. PubMed ID: 7856302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-epitope vaccine provided efficient protection to mice against lethal dose of influenza A virus H1N1.
    Wei H; Lenz SD; Thompson DH; Pogranichniy RM
    Viral Immunol; 2014 Feb; 27(1):14-9. PubMed ID: 24405102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
    Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
    J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-epitope DNA vaccination prevents exhaustion and facilitates a broad antiviral CD8+ T cell response during chronic viral infection.
    Bartholdy C; Stryhn A; Christensen JP; Thomsen AR
    J Immunol; 2004 Nov; 173(10):6284-93. PubMed ID: 15528367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin.
    Brazzoli M; Magini D; Bonci A; Buccato S; Giovani C; Kratzer R; Zurli V; Mangiavacchi S; Casini D; Brito LM; De Gregorio E; Mason PW; Ulmer JB; Geall AJ; Bertholet S
    J Virol; 2016 Jan; 90(1):332-44. PubMed ID: 26468547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
    Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of MHC class I diversification on influenza epitope-specific CD8+ T cell precursor frequency and subsequent effector function.
    Day EB; Charlton KL; La Gruta NL; Doherty PC; Turner SJ
    J Immunol; 2011 Jun; 186(11):6319-28. PubMed ID: 21536802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus.
    Lee YN; Lee YT; Kim MC; Gewirtz AT; Kang SM
    J Immunol; 2016 Mar; 196(6):2637-45. PubMed ID: 26864033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization.
    Fu TM; Friedman A; Ulmer JB; Liu MA; Donnelly JJ
    J Virol; 1997 Apr; 71(4):2715-21. PubMed ID: 9060624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The context of epitope presentation can influence functional quality of recalled influenza A virus-specific memory CD8+ T cells.
    Day EB; Zeng W; Doherty PC; Jackson DC; Kedzierska K; Turner SJ
    J Immunol; 2007 Aug; 179(4):2187-94. PubMed ID: 17675478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.